Abstract
Vulvar lichen sclerosus is a chronic inflammatory condition characterized by the thinning and atrophy of the skin and mucosa surrounding the vulva and anus. This study evaluates the efficacy of a treatment protocol utilizing blue-diode laser photobiomodulation in managing vulval lichen sclerosus symptoms in a cohort of 12 female patients. The treatment protocol consisted of laser sessions for 3 times a week for 2 weeks, and follow-up sessions over a 16-week period. Objective and subjective parameters were assessed before treatment, at the end of treatment, and at 4-month follow-up visits. Results demonstrated significant reductions in subjective symptoms such as itching and pain, as well as improvements in objective signs including erythema and fissures. No side effects were observed, indicating the safety and tolerability of laser treatment. These findings suggest that photobiomodulation can be an effective therapeutic option for patients with vulval lichen sclerosus, with future research aimed at refining treatment protocols and evaluating its long-term benefits.
Reference29 articles.
1. Kirtschig G, Becker K, Günthert A, et al (2015) Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol 29:e1-43. https://doi.org/10.1111/jdv.13136
2. Gulin SJ, Lundin F, Seifert O (2023) Comorbidity in patients with Lichen sclerosus: a retrospective cohort study. Eur J Med Res 28:338. https://doi.org/10.1186/s40001-023-01335-9
3. Lewis FM, Tatnall FM, Velangi SS, et al (2018) British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 178:839–853. https://doi.org/10.1111/bjd.16241
4. Sun XY, Xiao YP, Sun YX, et al (2024) [Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment]. Zhonghua Fu Chan Ke Za Zhi 59:56–63. https://doi.org/10.3760/cma.j.cn112141-20230909-00094
5. Zivanovic I, Gamper M, Fesslmeier D, et al (2024) Nd:YAG/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial. BJOG 131:740–749. https://doi.org/10.1111/1471-0528.17737